2[2]Graham MV,Purdy JA,Emami B,et al. Clinical dose-volume histogram analysis for peneumonitis after 3D treatment for non-small cell lung cancer(NSCLC). Int J Radiat Oncol Biol Phys, 1999; 45(2) :323～329.
3[3]Marks LB,Spencer DP,Sherouse GW,et al. The role of three dimensional functional lung in Radiation treatment planning:the functional dose-volume histogram. Int J radiat Oncol Biol Phys, 1995 ; 33(1):65～75.
4[4]Kwa SLS,Lebesque JV, Thenws JCM,et al. Radiation pneumonitis as a function of mean lung Dose:a analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys,1998;42(1):1～9.
5[5]Lyman J, Complication probabilty as assessed from dose-volume histograms. Radiation Research, 1985 ; 104 :S-13-19.
6[6]Kutcher g, Burman C, Brewster M, et al. Historgram reduction method of calculating complication probabilities for three-dimensional treatment planning evaluations. Int J Radiat Oncol Biol Phys,1991;21(1);137～146.
7[7]Burman C,Kutcher GB,Emami B,et al. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys,1991 ;21(1):109～122.
8[8]Emani B, Lyman I, Brown A,et al. Tolerance of normal tissue to therapeutic irratdiadion. Int J Radiat Oncol Biol Phys, 1991 ; 21 (1):109～122.
9[9]Lyman J, Wlobrast AB. Optimization of radiation therapy Ⅲ. A method of assessing complication from dose-volume histograms. Int J Radiat Oncol Biol Phys, 1987 ; 13 (1): 103 ～ 109.
10[10]Burman C,Kutcher GB,Emami B,et al. Calculation of complication probability factors for nonuniform normal tissue irradiation:the effective volume method. Int J Radiat Oncol Biol Phy. 1993;20 (3):613～625.
